Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10609 - 10616 of 12007 results
The Top 10 Changes Made to the 2012 Proposed Rule Under the Affordable Care Act’s Employer Shared Responsibility Rules by Recently Issued Final Regulations
February 24, 2014| Advisory| Viewpoint
A Guide to the FDA's Proposed Social Media Guidance
February 23, 2014| Blog| Viewpoint
San Francisco Employers – Heads Up, New Rules Governing The Use of Criminal Records
February 21, 2014| Blog| Viewpoint
"Sophisticated" Breach Exposes 300,000 Student Records at University of Maryland: 3 Questions You Should Ask
February 21, 2014| Blog| Viewpoint
Aloha to CPSC Counsel Joe Martyak & Welcome Back to Gib Mullan, Former CPSC General Counsel & Compliance Director
February 20, 2014| Blog| Viewpoint
2, 4, 6, 8…NFL Cheerleaders Not “Rah Rah-ing” About Pay Rate
February 20, 2014| Blog| Viewpoint
Complaint from BBB Triggers HarperCollins COPPA-Compliance Measures
February 20, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Mintz represented S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans and energy, in its $40 million Series B financing of Sojo Industries, an industrial automation company that utilizes robotics, mobility, and software to deliver packaging and assembly solutions to the food and beverage industry.
Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|
Health Law Diagnosed: PBM Update Spring 2025
June 10, 2025| Podcast|